The Qstent technology is antithrombotic.
The hemocompatibility was demonstrated in flow loop studies using whole human blood.
The Qstent technology results in reduced inflammatory response.
The biocompatibility was demonstrated in a swine coronary artery model.
Fast endothelialization ensures mid to long-term success.
Benefit for all vascular implants
The Qstent technology is coating-free and therefore compatible with vascular implants such as neurovascular stents, flow diverters and coils, peripheral stents, coronary stents (BMS and DES), etc... The surface technology allows management of hemocompatibility and tissue response.